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GeneticorepigeneticinactivationofthepathwayformedbytheFanconianemia(FA)andBRCA1proteinsoccursinseveralcancer
types, making the aﬀected tumors potentially hypersensitive to DNA cross-linkers and other chemotherapeutic agents. It has been
proposed that the inability of FA/BRCA-defective cells to form subnuclear foci of eﬀector proteins, such as FANCD2, can be used
as a biomarker to aid individualization of chemotherapy. We show that FANCD2 inactivation not only renders cells sensitive to
cross-links, but also oxidative stress, a common eﬀect of cancer therapeutics. Oxidative stress sensitivity does not correlate with
FANCD2 or RAD51 foci formation, but associates with increased γH2AX foci levels and apoptosis. Therefore, FANCD2 may pro-
tectcellsagainstcross-linksandoxidativestressthroughdistinctmechanisms,consistentwiththegrowingnotionthatthepathway
is not linear. Our data emphasize the need for multiple biomarkers, such as γH2AX, FANCD2, and RAD51, to capture all pathway
activities.
Copyright © 2008 Henning Willers et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Fanconi anemia (FA) is a heterogeneous clinical syndrome
characterized by bone marrow failure, congenital defects,
and cancer predisposition [1–5]. Cells derived from FA pa-
tientsexhibitmultipleabnormalitiesincludingchromosomal
instability and hypersensitivity to genotoxic agents, partic-
ularly drugs that cause DNA interstrand cross-links (ICLs),
such as mitomycin C (MMC). FA is caused by mutations in
any of the known 13 FANC genes, FANCA through FANCN
[2, 5–7]. The FANC proteins together with BRCA1 cooper-
ate in a common biochemical pathway, the FA/BRCA path-
way, which is believed to function mainly in the detection,
stabilization, and repair of stalled DNA replication forks
[2, 4]. A multiprotein nuclear core complex is required for
baseline and damage-induced monoubiquitination of the
downstream eﬀectors FANCD2 and FANCI [7]. In response
to DNA damage such as replication fork-blocking ICLs,
monoubiquitinated FANCD2 relocates into chromatin and
colocalizes with BRCA2/FANCD1, RAD51, and other DNA
damage response proteins; and these protein accumulations
canbevisualizedassubnuclearfoci[8–13].Disruptionofthe
nuclear core complex or mutation of FANCD2’s monoubiq-
uitination site at K561 impairs repair processes, including
homologous recombination, that are active at stalled forks
[8, 14]. These repair defects cause chromosomal aberrations,
particularly chromatid-type breaks and exchanges, and cell
death following ICL induction.
Inactivation of the FA/BRCA pathway by genetic or epi-
genetic mechanisms, which are frequently found in cancer,
can be detected by the inability of the aﬀected cells to form
FANCD2 foci in response to DNA damage [15, 16]. There is
currently great interest in using FANCD2 foci formation as a
functional biomarker to predict the sensitivity of cancer cells
to cross-linking drugs such as cisplatin [16].
In addition to ICL hypersensitivity, it has been proposed
that FA cells suﬀer from a prooxidant state that is associated
with overproduction or impaired detoxiﬁcation of reactive
oxygenspecies[17].CellswithdefectsintheFApathwaymay
demonstrate increased apoptosis, hypersensitivity to oxygen,2 Journal of Biomedicine and Biotechnology
excessive oxidative DNA damage after treatment with hydro-
gen peroxide (H2O2), improved growth when maintained
at low oxygen tension, or reduction of chromosomal aber-
rations after treatment with antioxidants [18–21]. At least
forFANCC,molecularmechanismshavebeenidentiﬁedthat
support a role in redox metabolism and apoptosis [22–24].
Mutational analysis dissociated FANCC’s participation in
apoptotic signaling pathways from its role in the response
to MMC [25]. Other FA proteins for which an involve-
mentinoxidativestressresponseshavebeenreportedinclude
FANCG, which not only participates in redox-regulated nu-
clear complex formation [26], but also locates to mitochon-
dria where it interacts with peroxidase to prevent oxidative
stress-induced apoptosis [27].
Importantly, the oxidative stress sensitivity caused by
FA/BRCA defects likely results in or contributes to cellular
chemosensitivity for various agents [28]. However, it is un-
known whether this sensitivity can be detected by abrogated
FANCD2 or RAD51 foci formation. Here, we use a human
model cell line to describe a dual function of FANCD2 that
protects against ICLs and oxidative damage through distinct
mechanisms, which cannot be encompassed by a single pro-
tein biomarker.
2. MATERIAL AND METHODS
2.1. Celllines
SV40-transformed ﬁbroblasts derived from patients with FA
group D2 (PD20 cells) or A (PD220) and their retrovi-
rally complemented counterparts expressing wild-type pro-
tein were obtained from the OHSU Fanconi anemia cell
repository [29]. Cells were maintained in αMEM with 2mM
glutamineand15%fetalbovineserum(Sigma-Aldrich,Saint
Louis, USA). All cell lines tested free of mycoplasma.
2.2. Cytotoxicityassays
Exponentially growing cells were incubated with 0–50μM
H2O2 atroomtemperaturefor2hoursor0–0.5μg/mLMMC
for1hour(bothSigma-Aldrich).Cellswereplatedforcolony
formation and stained after 14 days with methylene blue.
Apoptosis was measured 24–48 hours after treatment. For
scoring of apoptotic nuclei, cells were stained with DAPI
(10μg/mL). 500 nuclei per sample were examined with a ﬂu-
orescence microscope (Olympus BX51) and assessed for cell
morphology and apoptotic bodies. For detection of the sub-
G1 DNA fraction, cells were stained with 0.1mg/mL PI, con-
taining 0.5mg/mL RNase and 0.1% NP40 detergent, and as-
sayed by ﬂow cytometry (FACSCalibur, Becton Dickinson,
Franklin Lakes, USA). 30,000 cells were analyzed using Cel-
lQuest software. Sub-G1 populations were determined by
histogram gating.
2.3. Detectionofsubnuclearproteinfoci
Cells were seeded in chamber slides or onto cover slides
and treated with H2O2 (25μM) or MMC (0.25μg/mL). Af-
ter 0.5–5 hours, cells were ﬁxed for 15 minutes with 4%
paraformaldehyde at room temperature and permeabilized
for 10 minutes with 0.5% Triton X-100 (Sigma-Aldrich)
in phosphate-buﬀered saline. Following blocking with 10%
s e r u mf o r1h o u ra tr o o mt e m p e r a t u r e ,c e l l sw e r ei n c u -
bated for 2 hours at 37◦C with anti-γ-H2AX (1:100 di-
lution, #4411-PC-100 from Trevigen, Gaithersburg, USA),
anti-Rad51 (1:200, Ab-1 from Calbiochem, EMD Chem-
icals, San Diego, USA), or anti-FANCD2 (1:400, NB100-
182 from Novus, Novus Biological, Colorado, USA) anti-
body. This was followed by incubation with species-speciﬁc
ﬂuorescein- or Alexa-488-conjugated secondary antibody
(Pierce #31583 or Molecular Probes #A-21441). All slides
were counterstained with DAPI and visualized by ﬂuores-
cence microscopy. Only cells with nuclei containing more
than ﬁve foci were scored. At least 300 nuclei were examined
for each data point.
2.4. Cellcycleanalysis
Cell cycle distributions with and without H2O2 treatment
(25μM for 2 hours) were assessed using PI staining. To mea-
sureDNAsynthesisaftertreatmentwithH2O2 orionizingra-
diation (IR) (Siemens Stabilipan 2 X-ray generator, 250KVp,
Siemens Medical Systems, Malvern, USA), cells were pulse
labeled with 100μM (+)-5-bromo-2 -deoxyuridine (BrdU,
Sigma Aldrich) for 30 minutes at 37◦C, blocked with 0.5%
Tween 20, and incubated with anti-BrdU antibody (Becton
Dickinson) for 1hour at 37◦C. Subsequently, cells were in-
cubated with FITC-conjugated rabbit antimouse antibody
(Dako, Carpinteria, USA) at 37◦C for 45 minutes. BrdU-
positive nuclei were scored using ﬂuorescence microscopy
and at least 300 nuclei were counted for each data point.
2.5. Cytogeneticstudies
Analysis of chromosomal damage was performed as de-
scribed [30]. Lethal G1 aberrations were scored includ-
ing terminal and interstitial deletions as well as dicentric
chromosomes. For G2 aberrations, chromatid-type aberra-
tions such as chromatid fragments, isochromatid fragments,
translocationsaswellastri-andquadriradialswereexpressed
as breaks per cell.
3. RESULTS
3.1. FANCD2focionlypartiallyreﬂectproteinfunction
The ability of the FA pathway to remove replication fork
blocking ICLs is dependent upon intact FANCD2 func-
tion. Mutation of FANCD2 in immortalized human ﬁbrob-
lasts obtained from a patient with FA group D2 (PD20)
leadstoICLsensitivity(Figure 1(a))andabrogatedFANCD2
foci formation (not shown), while the wild-type comple-
mented derivative cell line (PD20-wtD2) was normal in this
regard. Accumulating evidence also links components of
the FA pathway to the cellular response to oxidative stress
[1, 17, 31, 32], but whether this process depends on foci
formation as well was unknown. To address this question,
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do not cause measurable DNA double-strand breaks (DSBs).
We discovered that PD20 cells were signiﬁcantly more sen-
sitive to H2O2 than the PD20-wtD2 cells expressing wild-
type FANCD2 (Figure 1(b)), which has not been described
previously. Surprisingly, while H2O2 was a potent inducer
of FANCD2 foci in cells with a functional FA pathway
(Figure 2(a)), FANCA-mutant PD220 ﬁbroblasts were not
hypersensitive to H2O2 despite an inability of these cells to
form FANCD2 foci (Figure 2(b)). This suggested that the as-
pect of FANCD2 function that depends on foci formation is
notrequiredformediatingresistancetooxidativeDNAdam-
age.
3.2. FANCD2mediatesresistancetooxidativedamage
independentlyofitsfunctioninthereplication-
associatedDNAdamageresponse
RAD51 subnuclear foci are thought to reﬂect sites of ho-
mologous recombination, which is required for the repair
and restart of stalled replication forks [2]. Accordingly, PD20
cells,whicharehypersensitivetothecross-linkerMMC,were
unable to mount an RAD51 foci response following MMC
exposure (Figures 3(a) and 3(b)). In contrast, PD20 cells
w e r ec l e a r l ya b l et of o r mR A D 5 1f o c ii nr e s p o n s et oH 2O2,
which was comparable to the foci formation seen in PD20-
wtD2 cells exposed to the same H2O2 concentration. Next,
we asked whether the oxidative damage-induced S-phase
checkpoint also remained intact in PD20 cells. As reported
previously [33], PD20 cells continued to incorporate BrdU
following IR, indicating a defective S-phase checkpoint (ra-
dioresistant DNA synthesis) (Figure 3(c)). However, in re-
sponse to H2O2, PD20 cells demonstrated a decrease in DNA
synthesis indicating intact checkpoint function in response
to oxidative damage. We also analyzed cell cycle distributions
in response to H2O2 (Figure 3(d)) or IR (data not shown) to
ensurethatourobservationswerenotbiasedbymajorimbal-
ances in the position of cells in the cell cycle. We found that
the cell cycle proﬁles of PD20 and PD20-wtD2 cells, treated
or untreated, were almost identical.
3.3. IncreasedcytotoxicityinH2O2-treatedPD20cells
isnotassociatedwithinducedchromosomal
aberrationsbutincreasedapoptosis
Activation of the S-phase checkpoint by H2O2 (Figure 3(c))
suggested the presence of damaged DNA. We therefore stud-
ied γH2AX foci, which are typically used as markers of DSBs,
but may also reﬂect stalled replication forks or oxidative
damage [34, 35]. We discovered a substantial increase in the
formation of γH2AX foci in PD20, but not PD20-wtD2 cells
(Figures 4(a) and 4(b)). Next, we asked whether the increase
in DNA damage as marked by γH2AX foci led to the oc-
currence of chromosomal aberrations in H2O2-treated PD20
cells. Treatment of FA cells with cross-linkers such as MMC
ordiepoxybutanegenerallyresultsinamarkedlyelevatedfre-
quency of chromatid-type aberrations likely due to a fail-
ure to maintain and repair replication forks stalling at inter-
strand cross-links [2, 4]. Typical radial structures are found
in more than 20% of cells and the number of breaks per
cell may range from 1 to 20 [3, 36]. In contrast, exposure
of PD20 cells to H2O2 did not induce any radial formation
up to a concentration of 40μMo fH 2O2 despite the signiﬁ-
cant diﬀerence in clonogenic survival at doses up to 25μM.
We only recorded a mild increase in chromatid aberrations
up to 0.5 break per cell at 50μMo fH 2O2 (Figure 4(c)),
which is clearly distinct from the hallmark chromosomal
instability seen with cross-linkers yet consistent with the
normal RAD51 and S-phase checkpoint responses to H2O2
(Figure 3). The observed lack of signiﬁcant chromosomal in-
stability in response to H2O2 is also consistent with previous
observations [37]. To identify the mechanism of cell death,
we turned our attention to apoptosis endpoints. Using two
diﬀerent assays, we found that H2O2-treated PD20 cells ex-
hibited elevated levels of apoptosis compared to the wild-
type complemented cells (Figure 4(d)). In contrast, MMC
treatment does not typically induce increased apoptosis in
FANC-deﬁcient cells [38, 39]. Altogether, our data suggest
that the mode of cell death following oxidative damage is
not related to chromosomal aberrations that may arise due
to failed repair of stalled replication forks.
4. DISCUSSION
The formation of subnuclear FANCD2 foci in response to
d a m a g e dD N Ah a sb e e nr e g a r d e da saf u n c t i o n a lb i o m a r k e r
for the activity of the FA pathway [16, 40]. Here, we report
fortheﬁrsttimethattheability ofcellstoformFANCD2foci
only partially reﬂects the activity of the FANCD2-dependent
cytotoxic stress response. Speciﬁcally, FANCA-mutant cells
were not found to be sensitive to DNA damage caused by
H2O2 despite an inability to form FANCD2 foci (Figure 2).
In addition, we found that the MMC hypersensitivity, but
not the H2O2 hypersensitivity, of FANCD2-deﬁcient ﬁbrob-
lastswasassociatedwithanabrogationofRAD51fociforma-
tion(Figure 3)[38],suggestingdiﬀerentcellularresponsesto
the two agents. Of note, previous data on the ability of FA
cells to form damage-induced RAD51 foci have been some-
what inconsistent, possibly a reﬂection of the cell type under
study and the particular assay conditions [9–13]. Together,
our data suggest that neither FANCD2 nor RAD51 foci for-
mation adequately captures all activities of this pathway.
The mechanisms underlying the ICL and oxidative stress
hypersensitivity of FA cells have been controversial [17, 41].
The susceptibility to oxidative stress has long been recog-
nized as a general and uniform phenotype of primary cells
from FA patients, while cross-linker sensitivity appears to be
variable across complementation groups [1, 17, 21]. Saito
et al. [21] found that the oxygen hypersensitivity of primary
humanﬁbroblastcultureswaslostupontransformationwith
SV40 large T-Antigen, but the MMC hypersensitivity re-
mained. It was thus argued that oxygen hypersensitivity rep-
resents a “secondary” defectof FA cells.Yet, our data indicate
that SV40-transformed FANCD2-deﬁcient PD20 ﬁbroblasts
have retained their susceptibility to oxygen (assuming that
oxygen and H2O2 hypersensitivity are correlated). It is con-
ceivable that diﬀerences in cell culture conditions used for
establishing PD20 cells versus the cell lines reported by Saito
e ta l .h a v eh a dad i ﬀerential impact on oxygen sensitivities.4 Journal of Biomedicine and Biotechnology
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Figure 1: Hypersensitivity of FANCD2-deﬁcient human ﬁbroblasts to DNA damage. (a) Clonogenic survival of cells with or without wild-
type FANCD2 (PD20-wtD2 or PD20, resp.) after treatment with varying concentrations of MMC for one hour. (b) Analogously, clonogenic
survival after exposure to hydrogen peroxide (H2O2) for two hours. Data represent logarithmic means +/− standard error based on four
independent repeats.
Complemented Deﬁcient
FANCA
H2O2-induced FANCD2 foci
FANCD2
(a)
0.0001
0.001
0.01
0.1
1
S
u
r
v
i
v
a
l
f
r
a
c
t
i
o
n
0 5 10 15 20 25
H2O2 (μM)
FANCA wt complemented
FANCA deﬁcient
(b)
Figure 2: Resistance of FANCA-mutant cells with defective FANCD2 function to hydrogen peroxide (H2O2). (a) Representative images
illustrating staining for subnuclear FANCD2 foci in isogenic ﬁbroblast pairs, either deﬁcient for FANCD2 (PD20) or FANCA (PD220) and
their respective wild-type (wt) complemented counterparts. Foci were visualized three hours after treatment with H2O2 (25μMf o r2h o u r s ) .
(b) Clonogenic survival of cells with or without wild-type FANCA after treatment with varying concentrations of H2O2.D a t ar e p r e s e n t
logarithmic means +/− standard error from 15-repeat experiments.
Alternatively, FANCD2 may play a more important role in
the response to oxidative stress than other FA proteins such
as FANCA. We acknowledge that because our cells are SV40-
transformed, the p53 response is compromised; which could
aﬀect apoptosis, cell cycle proﬁles, and chromosomal aberra-
tions. It will therefore be important to expand our ﬁndings
to primary cell cultures.
The ICL resistance of cells is dependent upon the in-
tegrity of the nuclear FANC core complex, monoubiquiti-
nation, and subsequent chromatin localization of FANCD2
[8]. However, this model of the pathway appears to be in-
complete. For example, a phosphomutant of FANCE re-
stored FANCD2 monoubiquitination but not cross-linker
sensitivity of FANCE-deﬁcient lymphoblasts [42], and in a
chicken cell system components of the FANC core com-
plex mediated cross-linker resistance partly independent of
FANCD2monoubiquitinationandchromatintargeting[43].
These observations suggest that the FANC core complex tar-
gets additional proteins required for cross-linker resistance
and that nonubiquitinated FANCD2 may possess additionalHenning Willers et al. 5
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Figure 3: Normal DNA damage responses in FANCD2-deﬁcient cells treated with hydrogen peroxide (H2O2). (a) Illustration of RAD51
foci formation in PD20 and PD20-wtD2 cells 5 hours after exposure to MMC (0.25μg/mL for 1 hour) or H2O2 (25μM for 2 hours). (b)
Induction of RAD51 foci formation above background levels by MMC or H2O2. Because equal drug concentrations were used, rather than
isoeﬀective concentrations with regard to cell survival, the extent of foci induction between FANCD-deﬁcient and -complemented cells is
not directly comparable. Data represent means with upper standard error based on three independent repeats. (c) DNA synthesis measured
by BrdU pulse labeling in cells treated with ionizing radiation (IR, 8Gy) or H2O2 (25μM). Data represent means with upper standard error
based on two independent experiments. (d) Cell cycle distribution of propidium-iodide cell populations by ﬂow cytometry. A representative
experiment is shown. Percentages of cells in the G1, S, and G2 (and M) phases of the cell cycle are indicated.
cellular functions. The latter notion is supported by the
more severe phenotype of FANCD2−/− mice compared to
FANCA or FANCC knockouts [10]. Part of the phenotype of
FANCD2-deﬁcient cells may also reﬂect an impaired func-
tion of FANCI, which forms a complex with FANCD2 [7].
We favor the view that FANC proteins are multifunc-
tional proteins that form diﬀe r e n ts u b c o m p l e x e sw i t hs p e -
ciﬁc functions [1, 44]. In particular, FANCD2 appears to
have a dual role in distinct cellular pathways that respond
to replication fork damage and oxidative stress. Alterna-
tively, the mechanisms underlying the observed H2O2 and
ICL toxicity in FA cells may be overlapping, as discussed by
Pagano et al. [28].
Of note, the observation that H2O2 induces the forma-
tion of FANCD2 foci (Figure 2)[ 41], which presumably lo-
cate to replication forks, is consistent with a dual model
of function: various genotoxic stresses, including H2O2,h y -
droxyurea, or UV radiation, interfere with replication and
thereby recruit FANCD2 to replication forks. However, only
some types of DNA damage such as ICLs are severe enough
to subsequently require the repair-promoting function of
monoubiquitinated FANCD2, while cells exposed to UV or
H2O2 do not appear to depend on this mechanism for their
survival [11].
What are the molecular mechanisms by which FANCD2
protects against oxidative stress and apoptosis? Several in-
teractions of FANCC with prosurvival and redox pathways
have been reported [1, 22–24] and it is likely that FANCD2
possesses similar properties. Increased levels of γH2AX in
FANCD2-deﬁcient cells (Figure 4(b)) are consistent with an6 Journal of Biomedicine and Biotechnology
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Figure 4: DNA damage and cell survival as a function of FANCD2 status. (a) Representative images of the formation of γH2AX foci in PD20
versus wild-type complemented cells 30 minutes after completion of H2O2 treatment. (b) Quantiﬁcation of γH2AX foci response. Data
represent means with upper standard error based on two independent experiments. (c) G2-type chromosomal aberrations are expressed as
breakspercellasafunctionofincreasingH2O2 concentrationinFANCD2-deﬁcientandwild-typecomplementedPD20cells.Datarepresent
means with SEM based on at least three repeat experiments. (d) Apoptosis induction by H2O2 (50μM) in cells with or without wild-type
FANCD2 using ﬂuorescence microscopy to assess apoptotic morphology by DAPI staining and ﬂow cytometric analysis for sub-G1 DNA
content. Representative experiments based on the apoptotic response at 24 hours are shown (similar results were obtained at 48 hours and
with 25μMH 2O2).
impaired ability to protect the DNA against reactive oxy-
gen species, although we note that γH2AX foci may also re-
ﬂect apoptosis, senescence, or changes in chromatin confor-
mation that do not necessarily reﬂect DNA strand break-
age [34, 45, 46] .T h ef o r m e ri sr e l e v a n tt oo u ro b s e r v a t i o n
that these cells may also be more prone to undergo apop-
tosis in the presence of high levels of oxidative DNA dam-
age (Figure 4(d)). Interestingly, in a recent review article it
has been hypothesized that H2O2 induces the formation of a
complex containing FANCD2, FANCC, and STAT5 [1]. The
complex may be required for optimal phosphorylation of
STAT proteins, which function as nuclear transcription fac-
tors to promote cell survival.
In conclusion, the FA/BRCA pathway appears increas-
ingly multifunctional and heterogeneous. Elucidating the
precise roles of FANCD2 and other pathway members in
the response to diverse cytotoxic stresses will be impor-
tant for a better understanding of the chemosensitivity of
cancers, which frequently harbor defects in this pathway.
Multiplepredictivebiomarkers,includingγH2AX,FANCD2,
and RAD51 foci, are required for accurately identifying pre-
existing FA/BRCA defects in tumors and thus aiding individ-
ualization of therapy.
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